statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

10x Genomics Reports First Quarter 2024 Financial Results 10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif., April 30, 2024 PLEASANTON, Calif., April 30, 2024...

10x Genomics Reports First Quarter 2024 Financial Results

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 PR Newswire PLEASANTON, Calif., April 10...

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024

Shares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings...

10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Moderate Buy" from Analysts

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cathie Wood's ARK Investment bought 138K shares of 10x Genomics today

For the last three days, A.I.dvisor has detected that TXG's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

10x Genomics (TXG, $37.08) Aroon Indicator entered a Downtrend on April 01, 2024.

This is a Bullish indicator signaling TXG's price could rise from here. Traders may explore going long the stock or buying call options...

10x Genomics (TXG, $37.49) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 28, 2024

This indicator may be signaling TXG's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

10x Genomics (TXG, $37.49) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

10x Genomics (TXG, $37.49) Aroon Indicator entered a Downtrend on March 28, 2024.

10x Genomics (TXG, $36.9) Aroon Indicator entered a Downtrend on March 27, 2024.

This is a signal that TXG's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

10x Genomics (TXG, $36.9) RSI Indicator left the oversold zone on March 27, 2024

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Volume	6.51M
52-Wk High	$63.57
52-Wk Low	$24.60

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.48	--	--	N/A
Q1'24	-$0.50	-$0.50	0.36%	BEAT
Q4'23	-$0.35	-$0.41	-17.38%	MISSED
Q3'23	-$0.46	-$0.79	-71.58%	MISSED
Q2'23	-$0.40	-$0.53	-32.66%	MISSED

TXG 10x Genomics Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals